Literature DB >> 11910197

Lonomia genus caterpillar envenomation: clinical and biological aspects.

C L Arocha-Piñango1, B Guerrero.   

Abstract

Persons who have been in contact with Lonomia achelous or Lonomia obliqua caterpillars present external and internal bleeding and opening of recently healed wounds. Hematological tests show normal platelet count, prolonged prothrombin time, activated partial thromboplastin time and thrombin time, totally corrected by normal plasma. Decreased fibrinogen (Fg), factor (F) V, FXIII, plasminogen and alpha(2)-antiplasmin with increased FVIII: C, von Willebrand factor, Fg degradation products and D dimers. Tissue plasminogen activator, plasminogen activator inhibitor and protein C varied. In L. achelous biological fluids, compounds with anticoagulant or procoagulant properties have been identified. In L. obliqua bristle extracts, mainly procoagulant activities have been identified. Subcutaneous injections of L. achelous crude extracts and a semipurified fraction reduce Fg, plasminogen and FXIII in rabbits. Intravenous injections of a very purified fraction of L. achelous in rabbits produce lysis of preformed thrombi, a decrease of Fg, plasminogen, alpha(2)-antiplasmin, FXIII and inhibition of postthrombolytic thrombus growth. Subcutaneous injections of L. obliqua bristle extracts prolong prothrombin time and activated partial thromboplastin time and reduce FXIII. Intravenous injections of crude bristle extract and a purified fraction of L. obliqua induce disseminated intravascular coagulation. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11910197     DOI: 10.1159/000048075

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  8 in total

1.  A catalog for the transcripts from the venomous structures of the caterpillar Lonomia obliqua: identification of the proteins potentially involved in the coagulation disorder and hemorrhagic syndrome.

Authors:  Ana B G Veiga; José M C Ribeiro; Jorge A Guimarães; Ivo M B Francischetti
Journal:  Gene       Date:  2005-08-01       Impact factor: 3.688

2.  Caterpillar-induced bleeding syndrome in a returning traveller.

Authors:  Kris Chan; Adrienne Lee; Rodrigo Onell; Wai Etches; Susan Nahirniak; Sean M Bagshaw; Loree M Larratt
Journal:  CMAJ       Date:  2008-07-15       Impact factor: 8.262

3.  Effectiveness of Lonomia antivenom in recovery from the coagulopathy induced by Lonomia orientoandensis and Lonomia casanarensis caterpillars in rats.

Authors:  Ida S Sano-Martins; Camila González; Isabelle Valle Anjos; Juana Díaz; Luis Roberto C Gonçalves
Journal:  PLoS Negl Trop Dis       Date:  2018-08-16

4.  A review on Respiratory allergy caused by insects.

Authors:  Kausar Mohd Adnan
Journal:  Bioinformation       Date:  2018-12-22

5.  Diversity, phylogenetic distribution, and origins of venomous catfishes.

Authors:  Jeremy J Wright
Journal:  BMC Evol Biol       Date:  2009-12-04       Impact factor: 3.260

6.  Probable chronic renal failure caused by Lonomia caterpillar envenomation.

Authors:  Poliana Abrantes Schmitberger; Tássia Clara Fernandes; Robson Corrêa Santos; Rafael Campos de Assis; Andréia Patrícia Gomes; Priscila Karina Siqueira; Rodrigo Roger Vitorino; Eduardo Gomes de Mendonça; Maria Goreti de Almeida Oliveira; Rodrigo Siqueira-Batista
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2013-06-03

7.  Effects of Lonomia obliqua Venom on Vascular Smooth Muscle Cells: Contribution of NADPH Oxidase-Derived Reactive Oxygen Species.

Authors:  João Alfredo Moraes; Genilson Rodrigues; Vany Nascimento-Silva; Mariana Renovato-Martins; Markus Berger; Jorge Almeida Guimarães; Christina Barja-Fidalgo
Journal:  Toxins (Basel)       Date:  2017-11-07       Impact factor: 4.546

8.  Effect of Lonomia obliqua Venom on Human Neutrophils.

Authors:  João Alfredo Moraes; Genilson Rodrigues; Daniel Guimarães-Bastos; Vany Nascimento-Silva; Erik Svensjö; Mariana Renovato-Martins; Markus Berger; Jorge Guimarães; Christina Barja-Fidalgo
Journal:  Toxins (Basel)       Date:  2021-12-18       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.